Baxter International, Inc. plans to invest approximately $60 million during the next five years to expand production capacity at its four manufacturing facilities in China to support sales growth in the company’s Medication Delivery and Renal businesses. “This investment symbolizes Baxter’s strong commitment to meeting local needs for critical products and advancing healthcare in China and across the Asia Pacific region,” said Peter J. Arduini, president of Baxter&...